Literature DB >> 28765478

Valacyclovir-associated neurotoxicity treated with intensification of peritoneal dialysis.

Bhanu Prasad1, Mark McIsaac2, Julie Toppings3.   

Abstract

We report a 57-year-old woman with end-stage renal disease (ESRD) on maintenance peritoneal dialysis (PD), who presented to the emergency room (ER) by ambulance with complaints of confusion and altered sensorium for 48 hours. She had been reviewed in a walk-in clinic 72 hours earlier and had been prescribed the standard 1000 mg three times per day of valacyclovir for an acute attack of shingles instead of 500 mg once a day on ESRD. In the ER, she received further 500 mg of intravenous acyclovir as herpes encephalitis was clinically suspected. CT of the brain and lumbar puncture were non-contributory to the diagnosis. Valacyclovir and acyclovir were discontinued when the diagnosis of valacyclovir-associated neurotoxicity became clinically evident. As the patient's Glasgow Coma Scale declined, we intensified her PD regimen from one to six exchanges per day and 24 hours later there was a significant neurological improvement. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Dialysis; Renal Intervention; Therapeutic Indications; Toxicology; Unwanted Effects / Adverse Reactions

Mesh:

Substances:

Year:  2017        PMID: 28765478      PMCID: PMC5623202          DOI: 10.1136/bcr-2017-220678

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Case files of the Harvard medical toxicology fellowship: valacyclovir neurotoxicity and unintentional overdose.

Authors:  Colin Huguenel; Diana Felton; Rebecca Bruccoleri; Steven Salhanick
Journal:  J Med Toxicol       Date:  2015-03

2.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

3.  Reversible mental status change and renal dysfunction associated with the use of high-dose oral valaciclovir therapy for acute retinal necrosis.

Authors:  Richard M H Lee; Martin Llewellyn; Angela Houston; Edward H Hughes
Journal:  Retin Cases Brief Rep       Date:  2012

Review 4.  Valacyclovir neurotoxicity: clinical experience and review of the literature.

Authors:  T Asahi; M Tsutsui; M Wakasugi; D Tange; C Takahashi; K Tokui; S Okazawa; H Okudera
Journal:  Eur J Neurol       Date:  2009-04       Impact factor: 6.089

5.  Valacyclovir-associated neurotoxicity in peritoneal dialysis patients.

Authors:  Dhara Chaudhari; David Ginn
Journal:  Am J Ther       Date:  2014 Nov-Dec       Impact factor: 2.688

6.  Valacyclovir and Acyclovir Neurotoxicity With Status Epilepticus.

Authors:  Sumedh S Hoskote; Narender Annapureddy; Atul K Ramesh; Keith Rose; James P Jones
Journal:  Am J Ther       Date:  2016 Jan-Feb       Impact factor: 2.688

7.  Intensification of peritoneal dialysis improves valacyclovir neurotoxicity.

Authors:  Chrysoula Pipili; Kostas Pantelias; Edmond Deda; Pandelis Tsiamalos; Evaggelos Kostis; Eirini Grapsa
Journal:  Ren Fail       Date:  2012-11-26       Impact factor: 2.606

  7 in total
  3 in total

1.  Valacyclovir-associated neurotoxicity among patients on hemodialysis and peritoneal dialysis: A nationwide population-based study.

Authors:  Yi-Chun Wang; Shu-Hui Juan; Ching-Hao Li; Chu-Lin Chou; Li-Ying Chen; Li-Nien Chien; Te-Chao Fang
Journal:  Front Med (Lausanne)       Date:  2022-09-20

2.  When a Seemingly Harmless Prescription Turns into Toxicity.

Authors:  Zurab Azmaiparashvili; Kevin Bryan Lo; Nawal Habib; Annie Hsieh
Journal:  Case Rep Med       Date:  2018-09-16

3.  Severe mental disorders following anti-retroviral treatment in a patient on peritoneal dialysis: A case report and literature review.

Authors:  Qi-En He; Min Xia; Guang-Hui Ying; Xue-Lin He; Jiang-Hua Chen; Yi Yang
Journal:  World J Clin Cases       Date:  2019-10-26       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.